Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

West Pharmaceutical Services (WST)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 7,095,369
  • Shares Outstanding, K 73,550
  • Annual Sales, $ 1,509 M
  • Annual Income, $ 143,600 K
  • 36-Month Beta 0.94
  • Price/Sales 4.66
  • Price/Cash Flow 27.54
  • Price/Book 6.00

Price Performance

See More
Period Period Low Period High Performance
1-Month
88.00 +9.97%
on 04/27/17
96.97 -0.21%
on 05/08/17
+12.77 (+15.20%)
since 04/26/17
3-Month
77.97 +24.11%
on 04/13/17
96.97 -0.21%
on 05/08/17
+12.64 (+15.02%)
since 02/24/17
52-Week
70.17 +37.91%
on 10/26/16
96.97 -0.21%
on 05/08/17
+23.07 (+31.30%)
since 05/26/16

Most Recent Stories

More News
West Announces Quarterly Dividend and Participation in Upcoming Investor Conferences

West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a third-quarter 2017 dividend of $0.13 per share. The dividend will be paid on August 2,...

WST : 96.72 (+0.26%)
West Announces First-Quarter 2017 Results

West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2017 and updated financial guidance for the full-year 2017.

WST : 96.72 (+0.26%)
Medical Product Stocks' Earnings on Apr 27: ZBH, RMD & More

Let's take a look at the major Medical products stocks slated to release their Jan-Mar 2017 quarter's reports on Apr 27.

ZBH : 119.11 (-0.16%)
RMD : 69.94 (-0.16%)
WST : 96.72 (+0.26%)
ALGN : 141.02 (-0.26%)
West to Host First-Quarter 2017 Conference Call

West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2017 financial results before...

WST : 96.72 (+0.26%)
Trump Amending AHCA: Is the Medical Device Space Anxious?

In a bid to save its face, the Trump administration is attempting to keep the American Health Care Act viable by proposing a new amendment to the bill.

ACHC : 41.97 (-1.29%)
ATHN : 133.99 (+0.49%)
BDX : 186.15 (-0.33%)
WST : 96.72 (+0.26%)
IRTC : 34.04 (-2.51%)
INGN : 89.04 (+0.11%)
THC : 17.22 (-2.10%)
West Announces Fourth-Quarter and Full-Year 2016 Results and Announces Quarterly Dividend

West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2016 and provided detailed financial guidance for full-year 2017.

WST : 96.72 (+0.26%)
MedTech Stocks' Q4 Earnings on Feb 16: LH, WST and MDRX

Let's take a look at the major MedTech stocks slated to release their fourth-quarter 2016 numbers on Feb 16.

MDRX : 11.46 (-0.26%)
WST : 96.72 (+0.26%)
LH : 141.17 (-0.44%)
Vial Adaptors for Reconstitution Drug Market to be Worth US$1.3 Billion by 2024: Reduced Risk of Needlestick Injuries Ups Demand, Notes TMR

ALBANY, New York, January 19, 2017 /PRNewswire/ --

BAX : 58.57 (-0.96%)
WST : 96.72 (+0.26%)
CAH : 73.15 (-0.39%)
Vial Adaptors for Reconstitution Drug Market to be Worth US$1.3 Billion by 2024: Reduced Risk of Needlestick Injuries Ups Demand, Notes TMR

The Global Vial Adaptor for Reconstitution Drug Market is fairly consolidated as top four players hold a leading share in the global market. A report by Transparency Market Research states that West Pharmaceutical...

BAX : 58.57 (-0.96%)
WST : 96.72 (+0.26%)
CAH : 73.15 (-0.39%)
Research Reports Coverage on Medical Supplies Stocks -- OraSure Technologies, Integra LifeSciences, Tandem Diabetes Care, and West Pharma

Stock-Callers.com shifts its attention to four Medical Instruments and Supplies equities, which are OraSure Technologies Inc. (NASDAQ: OSUR), Integra LifeSciences Holdings Corp. (NASDAQ: IART), Tandem...

OSUR : 14.86 (+0.41%)
TNDM : 0.82 (unch)
IART : 48.90 (-1.51%)
WST : 96.72 (+0.26%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More

Business Summary

West Pharmaceutical Services applies technologies to the process of bringing new drug therapies and healthcare products. West's technologies include the design and manufacture of packaging components for pharmaceutical, healthcare and consumer products; research and development of drug delivery systems;...

See More

Support & Resistance

2nd Resistance Point 97.69
1st Resistance Point 97.08
Last Price 96.72
1st Support Level 95.58
2nd Support Level 94.69

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.